HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joseph B. Shrager Larry R. Kaiser Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Singhal, S. Articles by Kaiser, L. R. Search for Related Content PubMed PubMed Citation Articles by Singhal, S. Articles by Kaiser, L. R. Related Collections Mediastinum

Ann Thorac Surg 2003;76:1635-1642
© 2003 The Society of Thoracic Surgeons

---

Original article: general thoracic

Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation

^a Section of General Thoracic Surgery, Division of Cardiothoracic Surgery, Department of Surgery,, Philadelphia, Pennsylvania, USA
^b Department of Radiation Oncology, Philadelphia, Pennsylvania, USA
^c Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, USA

^* Address reprint requests to Dr Kaiser, Department of Surgery, Hospital of the University of Pennsylvania, 4 Silverstein Pavilion, 3400 Spruce St, Philadelphia, PA 19104, USA.
e-mail: kaiser{at}uphs.upenn.edu

Presented at the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31–Feb 2, 2003.

BACKGROUND: Adjuvant radiation after resection of Masaoka stage II thymoma is widely advocated, but the evidence supporting it is controversial. Studies addressing this issue generally report few patients and lump all patients beyond stage I together in the analysis.

METHODS: We retrospectively compared outcomes of stage I and II thymomas treated by resection alone with thymomas treated by resection plus radiation. Histology was re-reviewed to confirm pathologic staging and resection margin status.

RESULTS: Between February 1992 and 2002, we performed 167 resections for thymoma. Of these, 70 patients were believed to have tumors in stage IIb or less intraoperatively, and all of these patients underwent complete resection. We reviewed the histopathology of 62 of 70 patients. Thirty thymomas demonstrated less than complete transcapsular microscopic invasion (stage I) and 40 thymomas demonstrated microscopic transcapsular invasion or macroscopic invasion into surrounding fatty tissue (stage II). Forty-seven patients underwent surgery without postoperative mediastinal radiotherapy. Dosages in the 23 radiated patients (3 stage I and 20 stage II) consisted of 45 to 55 Gy. Median follow-up was 70.3 months. Stage II patients who were radiated (n = 20) and those who were not radiated (n = 20) consisted of identical proportions in stages IIa and IIb. Two patients recurred (1 unradiated stage I patient and 1 radiated stage IIb patient). Overall 5-year survival rate was 91%. All who died were free of recurrence at time of death. Log-rank test showed no difference in Kaplan Meier survival curves (p = 0.32) between the radiated and unradiated groups.

CONCLUSIONS: These data support the contention that margin-negative surgical resection alone is sufficient treatment for both stages I and II thymoma.

This article has been cited by other articles:

				E. Davenport and R. A. Malthaner The role of surgery in the management of thymoma: a systematic review. Ann. Thorac. Surg., August 1, 2008; 86(2): 673 - 684. [Abstract] [Full Text] [PDF]

				O. Rena, E. Papalia, A. Oliaro, E. Ruffini, P. Filosso, D. Novero, G. Maggi, and C. Casadio Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 109 - 113. [Abstract] [Full Text] [PDF]

				R. F. Riedel and W. R. Burfeind Jr Thymoma: Benign Appearance, Malignant Potential Oncologist, September 1, 2006; 11(8): 887 - 894. [Abstract] [Full Text] [PDF]

				F. C. Detterbeck Clinical Value of the WHO Classification System of Thymoma Ann. Thorac. Surg., June 1, 2006; 81(6): 2328 - 2334. [Abstract] [Full Text] [PDF]

				W. Fang, W. Chen, G. Chen, and Y. Jiang Surgical Management of Thymic Epithelial Tumors: A Retrospective Review of 204 Cases Ann. Thorac. Surg., December 1, 2005; 80(6): 2002 - 2007. [Abstract] [Full Text] [PDF]

				B. V. Duwe, D. H. Sterman, and A. I. Musani Tumors of the Mediastinum Chest, October 1, 2005; 128(4): 2893 - 2909. [Abstract] [Full Text] [PDF]

				Y.-J. Cheng, E.-L. Kao, and S.-H. Chou Videothoracoscopic Resection of Stage II Thymoma: Prospective Comparison of the Results Between Thoracoscopy and Open Methods Chest, October 1, 2005; 128(4): 3010 - 3012. [Abstract] [Full Text] [PDF]

				C. R. Thomas Jr Time to Move Beyond Retrospective Analyses for Thymic Neoplasms and Conduct a Prospective Multi-Institutional Clinical Trial Ann. Thorac. Surg., December 1, 2004; 78(6): 2207 - 2207. [Full Text] [PDF]

				P. Strobel, A. Bauer, B. Puppe, T. Kraushaar, A. Krein, K. Toyka, R. Gold, M. Semik, R. Kiefer, W. Nix, et al. Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis J. Clin. Oncol., April 15, 2004; 22(8): 1501 - 1509. [Abstract] [Full Text] [PDF]